Dr. Maryam Tabatabai is the senior director of drug information for Magellan Rx Management. She provides oversight and actively engages in evidence-based writing, development of clinical policies, new drug evaluations, as well as specialty and traditional drug pipeline forecasting. Dr. Tabatabai provides leadership and serves on a number of key committees and is the editor-in-chief for several Magellan Rx Management clinical publications, including MRx Pipeline, Clinical Alert, and Trend Alert blog. Since obtaining her Doctor of Pharmacy degree, she has gained meaningful pharmacy and clinical experience in the community, academic, hospital, and ambulatory care settings. Upon completing her pharmacy practice residency, she joined Magellan where she has been a central clinical resource across the enterprise
